Med BioGene Company Top Insiders
| MBGNF Stock | USD 0.01 0.00 0.00% |
Med BioGene employs about 7 people. The company is managed by 2 executives with a total tenure of roughly 11 years, averaging almost 5.0 years of service per executive, having 3.5 employees per reported executive. Examination of Med BioGene's management performance can provide insight into the company performance.
| Ibrahim Ghobrial Executive Chief Officer |
| FGS PEng Insider Chairman CEO |
Med |
Med BioGene Management Team Effectiveness
The company has return on total asset (ROA) of (2.4799) % which means that it has lost $2.4799 on every $100 spent on assets. This is way below average. Med BioGene's management efficiency ratios could be used to measure how well Med BioGene manages its routine affairs as well as how well it operates its assets and liabilities.Med BioGene Workforce Comparison
Med BioGene is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 727. Med BioGene maintains roughly 7.0 in number of employees contributing less than 1% to equities under Health Care industry.
Med BioGene Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Med BioGene Price Series Summation is a cross summation of Med BioGene price series and its benchmark/peer.
Med BioGene Notable Stakeholders
A Med BioGene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Med BioGene often face trade-offs trying to please all of them. Med BioGene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Med BioGene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ibrahim Ghobrial | Chief Officer | Profile | |
| FGS PEng | Chairman CEO | Profile |
About Med BioGene Management Performance
The success or failure of an entity such as Med BioGene often depends on how effective the management is. Med BioGene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Med management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Med management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Previously, it was engaged in the life science business with a focus on the development and commercialization of genomic-based clinical tests for non-small-cell lung cancer. Med BioGene Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada. Med Biogene operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Med BioGene Workforce Analysis
Traditionally, organizations such as Med BioGene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Med BioGene within its industry.Med BioGene Manpower Efficiency
Return on Med BioGene Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 8.6K | |
| Net Loss Per Executive | 30K |
Complementary Tools for Med Pink Sheet analysis
When running Med BioGene's price analysis, check to measure Med BioGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Med BioGene is operating at the current time. Most of Med BioGene's value examination focuses on studying past and present price action to predict the probability of Med BioGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Med BioGene's price. Additionally, you may evaluate how the addition of Med BioGene to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |